Karen Klugo MD in Blue Ash, Ohio

Home Ohio Blue Ash

Karen Klugo MD has Ophthalmology as her primary medical specialty. Their primary office is: 1945 Cei Dr in Blue Ash, Ohio.

They're a part of the: Cei Physicians Psc, Llc medical group which has around 147 members. You can call their office at 513-5133 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Ohio State University College Of Medicine and graduated in 1999 (around 25 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Karen Klugo MD Office Phone and Directions

Karen Klugo MD
Cei Physicians Psc, Llc
1945 Cei Dr
Blue Ash, Ohio 45242
513-5133

Patient Ratings
Please rate your experience with Karen Klugo MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 513-5133

Enter a starting address:

Healthcare Info for Karen Klugo MD

Medical School: Ohio State University College Of Medicine
Graduation Year: 1999
The Primary Medical Specialty for Karen Klugo MD is listed as: Ophthalmology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 0446268486
NPI #: 1306833496
NPI Created On: 10/04/2005
NPI Last Updated Listed as: 12/31/2013
Primary Taxonomy Code: 207W00000X
License Number:
35 07 99944 L
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Blue Cross Blue Shield
MOLINA HEALTHCARE OF OHIO
Humana
CareSource
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Not Assigned.

Services and Procedures include:

Removal of recurring cataract in lens capsule using laser
Removal of cataract with insertion of lens
Ultrasound of corneal structure and measurement
Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits
Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits
Examination of cornea and iris using lens device and slit lamp
Measurement of field of vision during daylight conditions
Diagnostic imaging of optic nerve of eye
Diagnostic imaging of retina
Measurement of corneal curvature and depth of eye
New patient office or other outpatient visit, typically 30 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792837611

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: LUMIGAN

Open Associated Drug #1: 0023-3205-03

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792837613

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: LUMIGAN

Open Associated Drug #1: 0023-3205-03

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792837615

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: LUMIGAN

Open Associated Drug #1: 0023-3205-03

Payments Total: $1,400

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 801698861

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $1,950

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 802339923

Being Disputed:: No

Product Related: No

Payments Total: $1,400

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 802454913

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $1,400

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 803187085

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812754433

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: XIIDRA

Open Associated Drug #1: 0078-0911-12

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812754435

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: XIIDRA

Open Associated Drug #1: 0078-0911-12

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 815647107

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Ocular

Name of Drug #1: INVELTYS

Open Associated Drug #1: 71571-121-28

Drug or Biological: Drug

Product Category #2: Ocular

Name Of Drug #2:: EYSUVIS

Associated Drug #2: 71571-333-83